Molecular conversion of muscarinic acetylcholine receptor M(5) to muscarinic toxin 7 (MT7)-binding protein
- PMID: 22174976
- PMCID: PMC3237002
- DOI: 10.3390/toxins3111393
Molecular conversion of muscarinic acetylcholine receptor M(5) to muscarinic toxin 7 (MT7)-binding protein
Abstract
Muscarinic toxin 7 (MT7) is a mamba venom peptide that binds selectively to the M(1) muscarinic acetylcholine receptor. We have previously shown that the second (ECL2) and third (ECL3) extracellular loops of the M(1) receptor are critically involved in binding the peptide. In this study we used a mutagenesis approach on the M(5) subtype of the receptor family to find out if this possesses a similar structural architecture in terms of toxin binding as the M(1) receptor. An M(5) receptor construct (M(5)-E(175)Y(184)E(474)), mutated at the formerly deciphered critical residues on ECL2 and 3, gained the ability to bind MT7, but with rather low affinity as determined in a functional assay (apparent K(i) = 24 nM; apparent K(i) for M(1) = 0.5 nM). After screening for different domains and residues, we found a specific residue (P(179) to L in M(5)) in the middle portion of ECL2 that was necessary for high affinity binding of MT7 (M(5)-EL(179)YE, apparent K(i) = 0.5 nM). Mutation of P(179) to A confirmed a role for the leucine side chain in the binding of MT7. Together the results reveal new binding interactions between receptors and the MT7 peptide and strengthen the hypothesis that ECL2 sequence is of utmost importance for MT binding to muscarinic receptors.
Keywords: G protein-coupled receptor; acetylcholine receptor; ligand binding; muscarinic toxin.
Figures





Similar articles
-
Muscarinic toxin 7 selectivity is dictated by extracellular receptor loops.J Biol Chem. 2004 Dec 3;279(49):50923-9. doi: 10.1074/jbc.M406424200. Epub 2004 Sep 27. J Biol Chem. 2004. PMID: 15452105
-
Structural model of ligand-G protein-coupled receptor (GPCR) complex based on experimental double mutant cycle data: MT7 snake toxin bound to dimeric hM1 muscarinic receptor.J Biol Chem. 2011 Sep 9;286(36):31661-75. doi: 10.1074/jbc.M111.261404. Epub 2011 Jun 17. J Biol Chem. 2011. PMID: 21685390 Free PMC article.
-
Different interactions between MT7 toxin and the human muscarinic M1 receptor in its free and N-methylscopolamine-occupied states.Mol Pharmacol. 2008 Dec;74(6):1554-63. doi: 10.1124/mol.108.050773. Epub 2008 Sep 10. Mol Pharmacol. 2008. PMID: 18784346
-
Snake toxins that bind specifically to individual subtypes of muscarinic receptors.Life Sci. 2001 Apr 27;68(22-23):2541-7. doi: 10.1016/s0024-3205(01)01050-5. Life Sci. 2001. PMID: 11392624 Review.
-
m1-toxin.Life Sci. 1993;52(5-6):433-40. doi: 10.1016/0024-3205(93)90299-i. Life Sci. 1993. PMID: 8441325 Review.
Cited by
-
Structure and selectivity engineering of the M1 muscarinic receptor toxin complex.Science. 2020 Jul 10;369(6500):161-167. doi: 10.1126/science.aax2517. Science. 2020. PMID: 32646996 Free PMC article.
References
-
- Caulfield M.P., Birdsall N.J. International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol. Rev. 1998;50:279–290. - PubMed
-
- Wess J. Muscarinic acetylcholine receptor knockout mice: Novel phenotypes and clinical implications. Annu. Rev. Pharmacol. Toxicol. 2004;44:423–450. - PubMed
-
- Eglen R.M., Choppin A., Dillon M.P., Hegde S. Muscarinic receptor ligands and their therapeutic potential. Curr. Opin. Chem. Biol. 1999;3:426–432. - PubMed
-
- Eglen R.M., Choppin A., Watson N. Therapeutic opportunities from muscarinic receptor research. Trends Pharmacol. Sci. 2001;22:409–414. - PubMed
-
- Heinrich J.N., Butera J.A., Carrick T., Kramer A., Kowal D., Lock T., Marquis K.L., Pausch M.H., Popiolek M., Sun S.C., Tseng E., Uveges A.J., Mayer S.C. Pharmacological comparison of muscarinic ligands: Historical versus more recent muscarinic M1-preferring receptor agonists. Eur. J. Pharmacol. 2009;605:53–56. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources